Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2009 (2009), Article ID 410260, 7 pages
http://dx.doi.org/10.1155/2009/410260
Methodology Report

Efficient siRNA Delivery by the Cationic Liposome DOTAP in Human Hematopoietic Stem Cells Differentiating into Dendritic Cells

Dipartimento di Medicina Sperimentale e Scienze Biochimiche, Sezione di Biochimica e Biologia Molecolare, Università di Perugia, Via del Giochetto, 06100 Perugia, Italy

Received 11 December 2008; Accepted 20 March 2009

Academic Editor: Bibekanand Mallick

Copyright © 2009 Sabata Martino et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. E. Martin and N. J. Caplen, “Applications of RNA interference in mammalian systems,” Annual Review of Genomics and Human Genetics, vol. 8, pp. 81–108, 2007. View at Publisher · View at Google Scholar
  2. D. E. Root, N. Hacohen, W. C. Hahn, E. S. Lander, and D. M. Sabatini, “Genome-scale loss-of-function screening with a lentiviral RNAi library,” Nature Methods, vol. 3, no. 9, pp. 715–719, 2006. View at Publisher · View at Google Scholar
  3. M. Boutros and J. Ahringer, “The art and design of genetic screens: RNA interference,” Nature Reviews Genetics, vol. 9, no. 7, pp. 554–566, 2008. View at Publisher · View at Google Scholar
  4. D. Bumcrot, M. Manoharan, V. Koteliansky, and D. W. Y. Sah, “RNAi therapeutics: a potential new class of pharmaceutical drugs,” Nature Chemical Biology, vol. 2, no. 12, pp. 711–719, 2006. View at Publisher · View at Google Scholar
  5. A. Orlacchio, G. Bernardi, A. Orlacchio, and S. Martino, “RNA interference as a tool for Alzheimer's disease therapy,” Mini-Reviews in Medicinal Chemistry, vol. 7, no. 11, pp. 1166–1176, 2007. View at Publisher · View at Google Scholar
  6. A. Orlacchio, G. Bernardi, A. Orlacchio, and S. Martino, “Patented therapeutic RNAi strategies for neurodegenerative diseases of the CNS,” Expert Opinion on Therapeutic Patents, vol. 18, no. 10, pp. 1161–1174, 2008. View at Publisher · View at Google Scholar
  7. D. H. Kim and J. J. Rossi, “Strategies for silencing human disease using RNA interference,” Nature Reviews Genetics, vol. 8, no. 3, pp. 173–184, 2007. View at Publisher · View at Google Scholar
  8. S. M. Elbashir, J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, and T. Tuschl, “Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells,” Nature, vol. 411, no. 6836, pp. 494–498, 2001. View at Publisher · View at Google Scholar
  9. D.-H. Kim, M. A. Behlke, S. D. Rose, M.-S. Chang, S. Choi, and J. J. Rossi, “Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy,” Nature Biotechnology, vol. 23, no. 2, pp. 222–226, 2005. View at Publisher · View at Google Scholar
  10. J. Moffat, J. H. Reiling, and D. M. Sabatini, “Off-target effects associated with long dsRNAs in Drosophila RNAi screens,” Trends in Pharmacological Sciences, vol. 28, no. 4, pp. 149–151, 2007. View at Publisher · View at Google Scholar
  11. S. A. Stewart, D. M. Dykxhoorn, D. Palliser et al., “Lentivirus-delivered stable gene silencing by RNAi in primary cells,” RNA, vol. 9, no. 4, pp. 493–501, 2003. View at Publisher · View at Google Scholar
  12. M. Li and J. J. Rossi, “Lentiviral vector delivery of siRNA and shRNA encoding genes into cultured and primary hematopoietic cells,” Methods in Molecular Biology, vol. 433, pp. 287–299, 2008. View at Publisher · View at Google Scholar
  13. O. ter Brake, K. 't Hooft, Y. P. Liu, M. Centlivre, K. J. von Eije, and B. Berkhout, “Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition,” Molecular Therapy, vol. 16, no. 3, pp. 557–564, 2008. View at Publisher · View at Google Scholar
  14. R. S. Pillai, S. N. Bhattacharyya, and W. Filipowicz, “Repression of protein synthesis by miRNAs: how many mechanisms?” Trends in Cell Biology, vol. 17, no. 3, pp. 118–126, 2007. View at Publisher · View at Google Scholar
  15. S. Vasudevan, Y. Tong, and J. A. Steitz, “Switching from repression to activation: microRNAs can up-regulate translation,” Science, vol. 318, no. 5858, pp. 1931–1934, 2007. View at Publisher · View at Google Scholar
  16. D. H. Kim, P. Sætrom, O. Snøve Jr., and J. J. Rossi, “MicroRNA-directed transcriptional gene silencing in mammalian cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 42, pp. 16230–16235, 2008. View at Publisher · View at Google Scholar
  17. F. Di Nunzio, B. Piovani, F.-L. Cosset, F. Mavilio, and A. Stornaiuolo, “Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein,” Human Gene Therapy, vol. 18, no. 9, pp. 811–820, 2007. View at Publisher · View at Google Scholar
  18. L. H. Li, P. McCarthy, and S. W. Hui, “High-efficiency electrotransfection of human primary hematopoietic stem cells,” The FASEB Journal, vol. 15, no. 3, pp. 586–588, 2001. View at Google Scholar
  19. J. M. Wiehe, P. Ponsaerts, M. T. Rojewski et al., “mRNA-mediated gene delivery into human progenitor cells promotes highly efficient protein expression,” Journal of Cellular and Molecular Medicine, vol. 11, no. 3, pp. 521–530, 2007. View at Publisher · View at Google Scholar
  20. V. F. I. Van Tendeloo, H.-W. Snoeck, F. Lardon et al., “Nonviral transfection of distinct types of human dendritic cells: high-efficiency gene transfer by electroporation into hematopoietic progenitor- but not monocyte-derived dendritic cells,” Gene Therapy, vol. 5, no. 5, pp. 700–707, 1998. View at Publisher · View at Google Scholar
  21. G. Ferlazzo, J. Klein, X. Paliard, W.-Z. Wei, and A. Galy, “Dendritic cells generated from CD34+ progenitor cells with flt3 ligand, c-Kit ligand, GM-CSF, IL-4, and TNF-α are functional antigen-presenting cells resembling mature monocyte-derived dendritic cells,” Journal of Immunotherapy, vol. 23, no. 1, pp. 48–58, 2000. View at Publisher · View at Google Scholar
  22. R. Tiribuzi, S. Martino, E. Ciraci et al., “Non-redundant roles of cathepsins L, B and S in CD1a+ dendritic cells knocked-down for cathepsin S by RNA interference,” Minerva Biotecnologica, vol. 20, no. 2, pp. 59–67, 2008. View at Google Scholar
  23. S. Della Bella, S. Nicola, I. Timofeeva, M. L. Villa, A. Santoro, and A. C. Berardi, “Are interleukin-16 and thrombopoietin new tools for the in vitro generation of dendritic cells?” Blood, vol. 104, no. 13, pp. 4020–4028, 2004. View at Publisher · View at Google Scholar
  24. S. Martino, C. Emiliani, A. Orlacchio, R. Hosseini, and J. L. Stirling, “β-N-acetylhexosaminidases A and S have similar sub-cellular distributions in HL-60 cells,” Biochimica et Biophysica Acta, vol. 1243, no. 3, pp. 489–495, 1995. View at Publisher · View at Google Scholar
  25. K. Honey and A. Y. Rudensky, “Lysosomal cysteine proteases regulate antigen presentation,” Nature Reviews Immunology, vol. 3, no. 6, pp. 472–482, 2003. View at Publisher · View at Google Scholar
  26. L. Delamarre, M. Pack, H. Chang, I. Mellman, and E. S. Trombetta, “Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate,” Science, vol. 307, no. 5715, pp. 1630–1634, 2005. View at Publisher · View at Google Scholar
  27. D. A. Scudiero, R. H. Shoemaker, K. D. Paull et al., “Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines,” Cancer Research, vol. 48, no. 17, pp. 4827–4833, 1988. View at Google Scholar
  28. R. Kronenwett, U. Steidl, M. Kirsch, G. Sczakiel, and R. Haas, “Oligodeoxyribonucleotide uptake in primary human hematopoietic cells is enhanced by cationic lipids and depends on the hematopoietic cell subset,” Blood, vol. 91, no. 3, pp. 852–862, 1998. View at Google Scholar
  29. D. Orlic, J. Kajstura, S. Chimenti et al., “Bone marrow cells regenerate infarcted myocardium,” Nature, vol. 410, no. 6829, pp. 701–705, 2001. View at Publisher · View at Google Scholar
  30. C. E. Murry, M. H. Soonpaa, H. Reinecke et al., “Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts,” Nature, vol. 428, no. 6983, pp. 664–668, 2004. View at Publisher · View at Google Scholar
  31. T. Montier, P. Delépine, K. Le Ny et al., “KLN-5: a safe monocationic lipophosphoramide to transfect efficiently haematopoietic cell lines and human CD34+ cells,” Biochimica et Biophysica Acta, vol. 1665, no. 1-2, pp. 118–133, 2004. View at Publisher · View at Google Scholar
  32. X. Gao and L. Huang, “Cationic liposome-mediated gene transfer,” Gene Therapy, vol. 2, no. 10, pp. 710–722, 1995. View at Google Scholar
  33. A. W. Wong, S. J. Scales, and D. E. Reilly, “DNA internalized via caveolae requires microtubule-dependent, Rab7-independent transport to the late endocytic pathway for delivery to the nucleus,” The Journal of Biological Chemistry, vol. 282, no. 31, pp. 22953–22963, 2007. View at Publisher · View at Google Scholar
  34. J. Rejman, A. Bragonzi, and M. Conese, “Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes,” Molecular Therapy, vol. 12, no. 3, pp. 468–474, 2005. View at Publisher · View at Google Scholar
  35. P. Lampela, P. Soininen, A. Urtti, P. T. Männistö, and A. Raasmaja, “Synergism in gene delivery by small PEIs and three different nonviral vectors,” International Journal of Pharmaceutics, vol. 270, no. 1-2, pp. 175–184, 2004. View at Publisher · View at Google Scholar
  36. A. Bragonzi, G. Dina, A. Villa et al., “Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs,” Gene Therapy, vol. 7, no. 20, pp. 1753–1760, 2000. View at Publisher · View at Google Scholar
  37. H.-W. Liao and K.-W. Yau, “In vivo gene delivery in the retina using polyethylenimine,” BioTechniques, vol. 42, no. 3, pp. 285–288, 2007. View at Publisher · View at Google Scholar